CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLDN8 | Claudin 8 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLIC1 | Chloride intracellular channel 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLIC2 | Chloride intracellular channel 2 | Disease related genes Potential drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CLIC4 | Chloride intracellular channel 4 | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLIC6 | Chloride intracellular channel 6 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CLNS1A | Chloride channel, nucleotide-sensitive, 1A | Cytoskeleton related proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CNGA1 | Cyclic nucleotide gated channel alpha 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA1B | Defensin, alpha 1B | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
DYSF | Dysferlin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
FAM26D | Family with sequence similarity 26, member D | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
FXYD5 | FXYD domain containing ion transport regulator 5 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
FXYD6 | FXYD domain containing ion transport regulator 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
GABRB2 | Gamma-aminobutyric acid (GABA) A receptor, beta 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GAP43 | Growth associated protein 43 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
GJA4 | Gap junction protein, alpha 4, 37kDa | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJB2 | Gap junction protein, beta 2, 26kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GJC3 | Gap junction protein, gamma 3, 30.2kDa | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLRA1 | Glycine receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
GLRB | Glycine receptor, beta | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GNLY | Granulysin | Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GRIA3 | Glutamate receptor, ionotropic, AMPA 3 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GRIN1 | Glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Tissue enriched |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
HSPA1A | Heat shock 70kDa protein 1A | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
HSPA1B | Heat shock 70kDa protein 1B | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
HTN3 | Histatin 3 | Predicted secreted proteins Transporters
| | | | | Tissue enriched |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
KCNA2 | Potassium voltage-gated channel, shaker-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNA3 | Potassium voltage-gated channel, shaker-related subfamily, member 3 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNC3 | Potassium voltage-gated channel, Shaw-related subfamily, member 3 | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCND2 | Potassium voltage-gated channel, Shal-related subfamily, member 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCND3 | Potassium voltage-gated channel, Shal-related subfamily, member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNH2 | Potassium voltage-gated channel, subfamily H (eag-related), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNH3 | Potassium voltage-gated channel, subfamily H (eag-related), member 3 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNJ16 | Potassium inwardly-rectifying channel, subfamily J, member 16 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |